Lauren M. Manrai, NP

Dr. Vivek Srikar Yedavalli is currently an Associate Professor of Radiology and Radiological Science, Associate Professor of Neurology, the Director of Stroke, Neurovascular, and Perfusion Imaging at Johns Hopkins Hospital, Chief of Neuroradiology at Johns Hopkins Bayview Medical Center, and Assistant Director of the Department of Radiology Physician Scientist Incubator Program. Dr. Yedavalli has been recognized nationally as a translational stroke and perfusion imaging researcher and physician-scientist. Within one year of his appointment at Johns Hopkins, Dr. Yedavalli received the Radiological Society of North America (RSNA)’s Seed Grant using MRI spectroscopy for prognostication in subacute ischemic stroke. Dr. Yedavalli was then chosen as the inaugural recipient of the Johns Hopkins University Department of Radiology Physician Scientist Incubator Program (RAD-PSI), an internal grant that also confers funding and protected time for his stroke work. The following year, for applying his work on collateralization based on CT perfusion within acute ischemic stroke with artificial intelligence, Dr. Yedavalli was awarded the RSNA Scholar Grant. For his research endeavors, Dr. Yedavalli was previously chosen as the American Journal of Neuroradiology (AJNR) Editorial Fellow and then subsequently as a member of the Academy of Radiology and Biomedical Imaging Research’s Council of Early Career Investigators. Thereafter, for his novel translational applications of MRI perfusion techniques to stroke, Dr. Yedavalli was chosen as a Junior Fellow of the International Society of Magnetic Resonance Imaging in Medicine (ISMRM). Dr. Yedavalli became an Editorial Board member of Stroke and an Editor in Training for Stroke: Vascular and Interventional Neurology. For his research endeavors, Dr. Yedavalli was conferred the Junior Faculty Clinical Research Award in 2023. In addition to research, Dr. Yedavalli is an active member of a number of national committees with a strong interest in leadership. He is currently a member of the ASNR Research, Education, Social Media/Website, and Young Professionals Committees. He also served as the Co-Chair of the Social Media Committee for the ASFNR 2019. Previously, Dr. Yedavalli was an Illinois ACR RFS Delegate in 2017 and 2018. He will also be the ASNR’s AMA Representative at this upcoming meeting. Dr. Yedavalli’s interests additionally include educational and teaching endeavors. He was previously the recipient of the Department of Radiology Education Award during his residency training. He prefers a balanced teaching approach with trainees with focused learning while maintaining autonomy for a more productive learning environment. Dr. Yedavalli is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Stroke, Brain Aneurysm, Arteriovenous Malformation, Thrombectomy, and Rhizotomy. Dr. Yedavalli is board certified in American Board Of Radiology.

Dr. Julie Hoover-Fong is a Professor of Genetic Medicine and Pediatrics and Director of the Greenberg Center for Skeletal Dysplasias at Johns Hopkins University. Dr. Hoover-Fong holds a bachelor’s degree in Human Nutrition from The Ohio State University, where she also completed her medical degree. She received her Ph.D. in the Graduate Training Program in Clinical Investigation at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health. Dr. Hoover-Fong completed a pediatric internship and residency at Washington University in St. Louis and a fellowship in medical genetics at Johns Hopkins University in Baltimore. She joined the Johns Hopkins University faculty in 2002 and progressed to Professor of Genetic Medicine and Pediatrics in 2019. She practices and oversees the clinical operations, research and educational ventures for the patients, families and healthcare providers served by the Greenberg Center. Her clinical team develops and improves diagnostic and treatment guidelines for comprehensive care of patients with all types of bone conditions including dwarfism, orofacial clefting, craniosynostosis and more. Dr. Hoover-Fong also mentors and teaches medical students, residents and genetic medicine trainees. As an active clinical researcher, Dr. Hoover-Fong is the Principal Investigator of multiple global clinical trials for achondroplasia, the first multi-center, investigator-initiated natural history study for achondroplasia, and multiple clinical studies for patients with orofacial clefting, hypophosphatasia and other conditions. She is also a co-investigator on the ELSI and Phenotype Review Committees for the Mendel Project, a whole exome sequencing venture to identify the genetic cause of Mendelian conditions. From an institutional service perspective, Dr. Hoover-Fong serves on the Johns Hopkins Associate Professor Promotions Committee and the Advisory Committee for the Graduate Training Program in Clinical Investigation. She serves on the Medical Advisory Board of the Little People of America, is a member of the Miller-Coulson Academy of Clinical Excellence at Johns Hopkins University and is a charter member of the International Skeletal Dysplasia Management Consortium, publishing best practice guidelines for patients with skeletal dysplasias. Dr. Hoover-Fong is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Achondroplasia, Rhizomelic Syndrome, Spondyloepimetaphyseal Dysplasia Strudwick Type, Adenoidectomy, and Myringotomy. Dr. Hoover-Fong is board certified in American Board Of Medical Genetics And Genomics. Dr. Hoover-Fong is currently accepting new patients.

Catherine Chu is the director of the Division of Pediatric Neurology and the John M. Freeman Pediatric Epilepsy Center in the Johns Hopkins Department of Neurology, as well as the vice president of child neurology at the Kennedy Krieger Institute. As a child neurologist, epileptologist and clinical neurophysiologist, Dr. Chu cares for children diagnosed with epilepsy and disorders of the nervous system (neurophysiology). She specializes in electroencephalogram (also known as EEG) analysis, seizure localization, surgical planning and neuromodulation for adult and pediatric patients with difficult to control epilepsy. She is nationally and internationally recognized for her work identifying causes of and treatment options for cognitive dysfunction and seizures in epilepsy and neurodevelopmental disorders. Dr. Chu’s team specializes in identifying and developing tools to detect and understand brain rhythms that support complex cognitive functions throughout development, including how these rhythms are disrupted by seizures and neurodevelopmental disorders. Dr. Chu earned her medical degree and a master’s degree in social anthropology from Harvard University. She completed an internship in pediatrics at Massachusetts General Hospital, and then a residency in neurology and child neurology at Massachusetts General and Brigham and Women’s Hospital. After completing two fellowships at Massachusetts General, one in epilepsy and another in clinical neurophysiology, Dr. Chu earned a master’s degree in medical science, focused on clinical investigation, from Harvard Medical School. Dr. Chu is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Benign Rolandic Epilepsy, Epilepsy in Children, Seizures, Epilepsy, and Deep Brain Stimulation. Dr. Chu is board certified in American Board Of Psychiatry And Neurology. Dr. Chu is currently accepting new patients.